- Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
-
Kamrul-Hasan A, Alam MS, Talukder SK, Dutta D, Selim S
- KMID: 2552803
- Endocrinol Metab.
- 2024 Feb;39(1):109-126.
- doi: 10.3803/EnM.2023.1839
Background: No recent meta-analysis has holistically analyzed and summarized the efficacy and safety of omarigliptin in type 2 diabetes mellitus (T2DM). We conducted a meta-analysis to address this knowledge gap. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
